TAMARA SCHILSKY: Open Payments
NPI 1679167852 · NEW SMYRNA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,347 in 128 payments from 22 companies in 2025. Trend: 2023 $1,316 · 2024 $1,398 · 2025 $2,347
Food & beverage: $2,347
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $407 |
| Regeneron Healthcare Solutions, Inc. | 14 | $282 |
| GlaxoSmithKline, LLC. | 27 | $272 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $272 |
| Grifols USA, LLC | 12 | $209 |
| JAZZ PHARMACEUTICALS INC. | 9 | $189 |
| Insmed, Inc. | 10 | $142 |
| GENZYME CORPORATION | 5 | $113 |
| Viatris Specialty LLC | 4 | $85 |
| Amgen Inc. | 3 | $60 |
Products named: DUPIXENT, TRELEGY ELLIPTA, FASENRA, Prolastin-C Liquid, XYWAV, Arikayce, GLASSIA, HYQVIA.
Industry payments across FL — which companies pay providers there.
